Correlation Between Beam Therapeutics and EnGene Holdings
Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam Therapeutics and enGene Holdings Common, you can compare the effects of market volatilities on Beam Therapeutics and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and EnGene Holdings.
Diversification Opportunities for Beam Therapeutics and EnGene Holdings
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Beam and EnGene is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and EnGene Holdings go up and down completely randomly.
Pair Corralation between Beam Therapeutics and EnGene Holdings
Given the investment horizon of 90 days Beam Therapeutics is expected to generate 0.63 times more return on investment than EnGene Holdings. However, Beam Therapeutics is 1.59 times less risky than EnGene Holdings. It trades about 0.05 of its potential returns per unit of risk. enGene Holdings Common is currently generating about -0.01 per unit of risk. If you would invest 2,398 in Beam Therapeutics on September 25, 2024 and sell it today you would earn a total of 485.00 from holding Beam Therapeutics or generate 20.23% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 99.21% |
Values | Daily Returns |
Beam Therapeutics vs. enGene Holdings Common
Performance |
Timeline |
Beam Therapeutics |
enGene Holdings Common |
Beam Therapeutics and EnGene Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Beam Therapeutics and EnGene Holdings
The main advantage of trading using opposite Beam Therapeutics and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.Beam Therapeutics vs. Editas Medicine | Beam Therapeutics vs. Crispr Therapeutics AG | Beam Therapeutics vs. Caribou Biosciences | Beam Therapeutics vs. Verve Therapeutics |
EnGene Holdings vs. Beam Therapeutics | EnGene Holdings vs. Caribou Biosciences | EnGene Holdings vs. Intellia Therapeutics | EnGene Holdings vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |